FDA Approved: FLUCONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for fluconazole by Hikma Pharmaceuticals USA Inc., advancing the approval of this generic antifungal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Cryptococcal Meningitis
• Esophageal Candidiasis
• Oropharyngeal Candidiasis
• Vulvovaginal Candidiasis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)